We are live on ! Find out more
MBE

Michael B. Elefante Portfolio holdings

AUM $91.5M Turnover 27.89%
1-Year Est. Return 13.24%
This Fund
S&P 500
This Quarter Est. Return
+2.45%
1 Year Est. Return
+13.24%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$231M
AUM Growth
+$14.3M
Cap. Flow
+$10.4M
Cap. Flow %
4.51%
Top 10 Hldgs %
31.83%
Holding
146
New
35
Increased
57
Reduced
31
Closed
6
Avg Time Held
0.5 years
Top 10 Avg Time Held
0.7 years
Top 20 Avg Time Held
0.7 years

Top Buys

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$1.19M
2
TGT icon
Target
TGT
+$645K
3
XLNX
Xilinx Inc
XLNX
+$524K
4
FISV icon
Fiserv Inc
FISV
+$483K
5
IPGP icon
IPG Photonics
IPGP
+$386K

Top Sells

Rank Stock Value
1
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$595K
2
SYK icon
Stryker
SYK
+$258K
3
TEVA icon
Teva Pharmaceutical Industries Limited
TEVA
+$228K
4
GIS icon
General Mills
GIS
+$227K
5
COL
Rockwell Collins
COL
+$216K

Sector Composition

Rank Sector Weight
1 Technology 23.63%
2 Healthcare 23.62%
3 Industrials 17.11%
4 Energy 10.93%
5 Miscellaneous 9.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
CVS icon
1
CVS Health
CVS
$116B
$9M 3.89%
120,261
-710
-0.6% -$50.2K
2013 Q2
3 quarters
NVS icon
2
Novartis
NVS
$279B
$7.97M 3.45%
104,653
+2,478
+2% +$181K
2013 Q2
3 quarters
JNJ icon
3
Johnson & Johnson
JNJ
$612B
$7.93M 3.43%
80,710
-1,725
-2% -$160K
2013 Q2
3 quarters
EMR icon
4
Emerson Electric
EMR
$89.9B
$7.55M 3.27%
113,005
-2,585
-2% -$170K
2013 Q2
3 quarters
CNI icon
5
Canadian National Railway
CNI
$72.4B
$7.25M 3.14%
129,040
+640
+0.5% +$35.3K
2013 Q2
3 quarters
MA icon
6
Mastercard
MA
$528B
$7.17M 3.1%
95,940
+4,100
+4% +$320K
2013 Q2
3 quarters
PG icon
7
Procter & Gamble
PG
$364B
$7.02M 3.04%
87,116
+39
+0% +$3.07K
2013 Q2
3 quarters
MMM icon
8
3M
MMM
$84.8B
$6.41M 2.77%
56,527
-956
-2% -$106K
2013 Q2
3 quarters
COV
9
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$6.14M 2.66%
83,427
+3,680
+5% +$257K
2013 Q2
3 quarters
PEP icon
10
PepsiCo
PEP
$176B
$6.08M 2.63%
72,825
+265
+0.4% +$21.5K
2013 Q2
3 quarters
ATR icon
11
AptarGroup
ATR
$7.65B
$5.97M 2.58%
90,260
+1,575
+2% +$103K
2013 Q2
3 quarters
ADP icon
12
Automatic Data Processing
ADP
$111B
$5.82M 2.52%
85,829
+313
+0.4% +$21.3K
2013 Q2
3 quarters
ORCL icon
13
Oracle
ORCL
$396B
$5.8M 2.51%
141,729
+2,990
+2% +$114K
2013 Q2
3 quarters
EMC icon
14
DELISTED
EMC CORPORATION
EMC
$5.72M 2.47%
208,708
+13,300
+7% +$346K
2013 Q2
3 quarters
XOM icon
15
ExxonMobil
XOM
$728B
$5.55M 2.4%
56,845
+431
+0.8% +$41.1K
2013 Q2
3 quarters
AAPL icon
16
Apple
AAPL
$5.01T
$5.43M 2.35%
283,388
+18,340
+7% +$349K
2013 Q2
3 quarters
CVX icon
17
Chevron
CVX
$436B
$5M 2.16%
42,001
+2,965
+8% +$345K
2013 Q2
3 quarters
SLB icon
18
SLB Ltd
SLB
$72B
$4.88M 2.11%
50,015
+2,855
+6% +$258K
2013 Q2
3 quarters
ROK icon
19
Rockwell Automation
ROK
$47B
$4.79M 2.07%
38,445
+2,565
+7% +$304K
2013 Q2
3 quarters
INTC icon
20
Intel
INTC
$519B
$4.52M 1.96%
175,146
-5
-0% -$125
2013 Q2
3 quarters
FISV icon
21
Fiserv Inc
FISV
$24.5B
$4.35M 1.88%
153,420
+16,900
+12% +$483K
2013 Q2
3 quarters
NXPI icon
22
NXP Semiconductors
NXPI
$55.7B
$4.12M 1.78%
70,085
+4,160
+6% +$217K
2013 Q2
3 quarters
HP icon
23
Helmerich & Payne
HP
$3.86B
$4.11M 1.78%
38,175
+925
+2% +$86K
2013 Q2
3 quarters
ILMN icon
24
Illumina
ILMN
$41B
$4.02M 1.74%
27,818
+2,067
+8% +$304K
2013 Q2
3 quarters
PRGO icon
25
Perrigo
PRGO
$2.21B
$3.88M 1.68%
25,093
+1,785
+8% +$282K
2013 Q2
3 quarters
1
2 3 4 5

Similar funds

AEPI
AH Equity Partners II Menlo Park, California $91.5M AUM
CC
Columbia Capital Fullerton, California $91.6M AUM 27.93% 1-Year Est. Return
TM
TigerShark Management New York $98.9M AUM 11.4% 1-Year Est. Return
VNB
Valley National Bancorp New York $81.9M AUM 5.36% 1-Year Est. Return
ECP
Empirical Capital Partners Ringgold, Georgia $101M AUM
WIL
Winifred I. Li $106M AUM 11.93% 1-Year Est. Return
RCM
Raptor Capital Management Boston, Massachusetts $73.2M AUM 23.77% 1-Year Est. Return
ZTNA
Zions Trust National Association Salt Lake City, Utah $69.4M AUM 2.73% 1-Year Est. Return

Michael B. Elefante's Q1 2014 Portfolio in Review

As of Q1 2014, Michael B. Elefante held 146 positions worth $231M, up 6.6% from $217M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Michael B. Elefante deployed $10.4M of net new capital in Q1 2014, opening 35 new positions and adding to 57 existing holdings. Its largest new stake was CITY NATIONAL CORPORATION: 3,900 shares worth $307K.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Alnylam Pharmaceuticals, an estimated $595K trimmed.

  • Michael B. Elefante's largest Q1 2014 buy was CITY NATIONAL CORPORATION: 3,900 shares worth $307K.
  • Michael B. Elefante added most to Qualcomm in Q1 2014, an estimated $1.19M increase.
  • Michael B. Elefante's biggest Q1 2014 reduction was Alnylam Pharmaceuticals, cutting an estimated $595K.
  • Michael B. Elefante fully exited Stryker in Q1 2014, selling an estimated $258K.
  • Michael B. Elefante's ten largest holdings make up 32% of its $231M portfolio in Q1 2014.
  • Michael B. Elefante opened 35 new positions and closed 6 in Q1 2014.
  • Michael B. Elefante's portfolio value rose 6.6% quarter-over-quarter to $231M.

Based on Michael B. Elefante's 13F filing for Q1 2014, filed 29 May 2014.